This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n4http://linked.opendata.cz/resource/drugbank/drug/DB03737/identifier/pdb/
n14http://linked.opendata.cz/resource/drugbank/drug/DB03737/identifier/bindingdb/
n7http://linked.opendata.cz/resource/drugbank/drug/DB03737/identifier/pubchem-compound/
n15http://linked.opendata.cz/resource/drugbank/drug/DB03737/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB03737/identifier/drugbank/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n12http://linked.opendata.cz/resource/drugbank/drug/DB03737/identifier/chemspider/
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03737
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n9:DB03737 n10:DB03737
dcterms:title
4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One
adms:identifier
n4:FMD n7:5288222 n12:4450427 n13:DB03737 n14:10109 n15:46505468
n5:IUPAC-Name
n6:271B64A3-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B64A9-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B64A8-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B64A5-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B64A6-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B64A7-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B64A1-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B649F-363D-11E5-9242-09173F13E4C5 n6:271B64A2-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B64A0-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B64AF-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B64B0-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B64AA-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B64AB-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B64AD-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B64AC-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B64AE-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B64B5-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B64B7-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B64B8-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B64B4-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B64B3-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B64B6-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B64A4-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B64B1-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B64B2-363D-11E5-9242-09173F13E4C5